Does pulmonary hypertension affect mortality and functional status in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation?
Patients with severe aortic stenosis undergoing transcatheter aortic valve implantation
Presence of pulmonary hypertension (sPAP ≥40 mm Hg) or severe pulmonary hypertension (sPAP ≥60 mm Hg)
1-year mortalityhard clinical
Pulmonary hypertension is a predictor of 1-year mortality in patients undergoing TAVI for severe aortic stenosis, although functional status improves regardless of baseline pulmonary pressures.
PH (sPAP ≥40 mm Hg) in patients with aortic stenosis undergoing transcatheter aortic valve implantation was associated with increased 1-year mortality especially when severe (sPAP ≥60 mm Hg) but not with increased 30-day mortality, and functional status was significantly improved regardless of PAP level.
Building similarity graph...
Analyzing shared references across papers
Loading...
Adrien Luçon
Emmanuel Oger
Marc Bédossa
Circulation Cardiovascular Interventions
Inserm
Hôpital Bichat-Claude-Bernard
Hôpital Dupuytren
Building similarity graph...
Analyzing shared references across papers
Loading...
Luçon et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69aee158d10565c8f93c9b95 — DOI: https://doi.org/10.1161/circinterventions.113.000482